Through project selection and review, and periodic assessment of the program, the Oversight Committee ensures the quality of projects and the sustainability of the Partnership. The independent Oversight Committee, chaired by Dr. Barry Myers, includes members from Duke as well as industry and venture capital.

The committee members include:

Nate Dau, PhD

Senior Research Scientist, Digital Hardware at Under Armour and Biomedical/Medical Engineer


Richard Kent, PhD

Professor of Mechanical and Aerospace Engineering, Biomedical Engineering, and Emergency Medicine at the University of Virginia and Deputy Director of the Center for Applied Biomechanics


Alfred T. Malouf, PhD

Chief Consultant, Cortex Innovation; Principal and Cofounder at KGA Partners, LLC


Geoffrey T. Manley, MD, PhD

Chief of Neurosurgery at San Francisco General Hospital and Professor of Neurosurgery at the University of California San Francisco (UCSF)


Barry Myers, MD, PhD, MBA

Director of Innovation, Duke CTSI; Coulter Program Director and Professor of Biomedical Engineering at Duke University and a consultant to the NFLPA


Thom Parks

Vice President of Corporate Affairs at Bell Sports, Inc.


Jeff Terrell

Hatteras Venture Partners, Associate investing in early stage medical device, biopharmaceutical, healthcare IT, and diagnostic companies


Beth A. Winkelstein, PhD

Professor, BE and Associate Dean for Undergraduate Education, SEAS Research focuses: Orthopaedic Bioengineering, Injury Biomechanics, Experimental Neuroscience


Christopher Withnall

Senior Engineer, Biokinetics and Associates Ltd.


 Full biographies:

Nate Dau, PhD

Senior Research Scientist, Digital Hardware at Under Armour and Biomedical/Medical Engineer

daufinal

NATHAN DAU, PhD IS A SR. RESEARCH SCIENTIST with the digital hardware innovation group at Under Armour. A PhD in biomechanics from Wayne State University, Nate brings substantial experience in impact biomechanics and injury prevention to the Oversight Committee.  His more recent industrial work includes integration and development of wearable sensing systems that draw on his prior work and publications on football helmet sensing systems. He has also had significant experience with open innovation models in industry linking industrial needs with research goals.  Prior to working in industry, Nate’s oversaw research in a variety of settings including as Director of R&D at Northwest Impact Biomechanics.


Richard Kent, PhD

Professor of Mechanical and Aerospace Engineering, Biomedical Engineering, and Emergency Medicine at the University of Virginia and Deputy Director of the Center for Applied Biomechanics

kentfinal

RICHARD KENT, PhD IS A PROFESSOR OF MECHANICAL & AEROSPACE ENGINEERING, Biomedical Engineering, and Emergency Medicine at the University of Virginia and Deputy Director of the UVA Center for Applied Biomechanics.  Over the course of his 20-year career, Dr. Kent has published over 200 articles on the biomechanics of injury and the design and assessment of injury prevention countermeasures.  His research interests include experimental design and the development of test and analysis methods for relating mechanical loads to injury risk, and the use of that knowledge to improve the effectiveness of safety equipment. Dr. Kent has consulted to the NFL Player Health & Safety Committees since 2008.  His background as an international expert in automotive crash injury prevention has informed the league’s research to improve assessment tools for sports injury protection equipment.  Dr. Kent chaired the NFL Taskforce on the Development of Recommended Practices for Gameday Fields and has led the development of assessment methods for NFL shoulder pads, thigh pads, knee pads, and footwear, in addition to his ongoing work with the NFL’s Head, Neck and Spine Committee. Dr. Kent is a past Director and now Fellow of the Association for the Advancement of Automotive Medicine, a Fellow of the Society of Automotive Engineers, and a member of the Stapp Advisory Committee.


Alfred T. Malouf, PhD

Chief Consultant, Cortex Innovation; Principal and Cofounder at KGA Partners, LLC

malouffinalALFRED T. MALOUF, PhD RECEIVED A BA IN BIOLOGY FROM THE UNIVERSITY OF CALIFORNIA, SAN DIEGO, AND A PhD from the Department of Pharmacology and Experimental Therapeutics at The Johns Hopkins University School of Medicine. He served on the faculty at the University of Washington and Case Western Reserve University where his research focused on brain development and the causes of neuronal diseases, and was the recipient of a PEW Scholars Award in the Biomedical Sciences.  Dr. Malouf has been named as an inventor on two patent applications based on research performed at Case Western Reserve University and was co-founder of a biotechnology startup company. Dr. Malouf became further interested in the entrepreneurial aspects of science and technology, and he joined NineSigma where he was responsible for executing over 200 innovation projects for large corporations and for managing several Grand Challenges. Dr. Malouf’s Grand Challenge experience includes managing the first two NFL-GE-Under Armour Head Health Challenges, two environmental and sustainability Grand Challenges for LAUNCH (a consortium of the US Department of State, USAID, NASA and NIKE), two GE-Statoil Challenges to find more sustainable hydraulic fracturing methods, a Challenge to reduce malnutrition in developing countries for Scientists Without Borders, and a Challenge to develop a vaccine to fight HIV infections for The International Aids Vaccine Initiative (IAVI). Dr. Malouf currently works as an innovation consultant and on building a program to improve the transfer of technology between universities and industry.


Geoffrey T. Manley, MD, PhD

Chief of Neurosurgery at San Francisco General Hospital and Professor of Neurosurgery at the University of California San Francisco (UCSF)

manleyfinal

GEOFFREY T. MANLEY, MD, PhD IS THE CHIEF OF NEUROSURGERY at San Francisco General Hospital and Professor of Neurosurgery at the University of California San Francisco (UCSF). He is a trauma neurosurgeon with clinical interests in brain injury, spinal cord injury and neurocritical critical care. His translational research interests span from the laboratory to the bedside. Dr. Manley is a graduate of the Medical Scientist Training Program at Cornell University Medical College, where he earned his medical degree as well as his doctorate degree in Neuroscience. He completed his residency in Neurosurgery at UCSF and a Postdoctoral Fellowship in Molecular Biophysics. Dr. Manley is also a faculty member of the California Institute for Quantitative Biosciences and the UCSF Center for Clinical and Translational Informatics. Dr. Manley is an internationally recognized expert in neurotrauma. He has published over 120 manuscripts that reflect a wide range of research interests from molecular aspects of brain injury to the clinical care of head trauma patients. He has helped to define new molecular mechanisms of injury to the nervous system that may lead to new treatments for these devastating injuries. He is also considered a leader in the rapidly growing field of advanced neuromonitoring and clinical informatics for critical care. His many honors include the General Motors Trauma Research Award and the Trauma Research Award from the American College of Surgeons. He has served as a Consultant for the Prehospital Guidelines Committee for the World Health Organization and on a number of committees for the National Institutes of Health.


Barry Myers, MD, PhD, MBA

Director of Innovation, Duke CTSI; Coulter Program Director and Professor of Biomedical Engineering at Duke University and a consultant to the NFLPA

myersfinal

BARRY MYERS, MD, PhD, MBA HAS BEEN A MEMBER OF THE DUKE FACULTY in Biomedical Engineering, Orthopaedic Surgery, and Business Administration since 1991. Dr. Myers longstanding research examines catastrophic head and neck injury with the goal of injury prevention. He is considered by many as the preeminent researcher in his field worldwide, having over 100 manuscripts and publications on the subject. Among Dr. Myers many honors are the Stapp Award of Recognition, and the Isbrandt Award for automotive safety from the Society of Automotive Engineers.  He is the six-time winner of the Stapp Award for research in impact biomechanics, more than any other individual, and also the Bertil Aldman award for impact biomechanics research. Dr. Myers has worked with most major organizations concerned with safety in the United States including the National Highway Traffic Safety Administration, the Consumer Product Safety Commission and the National Operating Committee on Standards for Athletic Equipment, the NFL and the NFL-PA.  Because of his breadth of experience in injury prevention, Dr. Myers was appointed to the position of Senior Scientific Advisor to the National Center for Injury Prevention and Control for two years.   He has also consulted with most major automobile manufactures and automotive racing organizations worldwide. In addition to his research, he facilitates technology development, licensing, and industrial interaction serving as the founding Program Director for the Coulter Translational Research Partnership, and as Director of Innovation in the Duke Clinical and Translational Science Institute where he oversees translational funding totaling $2.5MM annually.  He was also responsible for the design, construction of the LEED Platinum Certified Duke Smarthome and the Duke University student technology incubator, DUHatch.  On a consulting basis, Dr. Myers serves as an Executive-in-Residence at Pappas Ventures, a bio-venture capital firm, and has advised and served on the boards of several life sciences start-up companies.


Thom Parks

Vice President of Corporate Affairs at Bell Sports, Inc.

parksfinal

THOM PARKS IS A VICE PRESIDENT OF CORPORATE AFFAIRS AT BELL SPORTS. Thom has 28 years of experience in safety including managing test laboratories and working on safety standards in sports and other settings.  His background includes managing helmet product development in a variety of applications including both one-time and repeat use helmets. Currently his portfolio includes bicycle, snow sport, and motorcycle helmets. Thom is a well-recognized expert in both the application of helmet technology and the business of bringing products to market in sports.


Jeff Terrell

Hatteras Venture Partners, Associate investing in early stage medical device, biopharmaceutical, healthcare IT, and diagnostic companies

terrellfinal

PRIOR TO JOINING THE HATTERAS TEAM IN 2012, Jeff Terrell worked in a sales and clinical support role for Medtronic, a large medical device company. Based in Georgia and South Carolina, Jeff worked in the operating room with neurosurgeons and orthopedic surgeons, selling and providing service on image-guided surgery equipment and spinal implants. Prior to working with Medtronic, Jeff devoted two years to pursuing a career as a professional quarterback, spending time with the Kansas City Chiefs and Dallas Cowboys. Since joining Hatteras, Jeff has worked in a corporate development role in a medical device portfolio company, and assisted in overall firm operations, deal flow activities and diligence. Jeff is a board observer at Medfusion, NeuroTronik, GrayBug, ORIG3N, Contego Medical, Wildflower Health and Medikidz. He holds a bachelor’s degree from Princeton University, and an MBA from Duke University, with a focus on healthcare and finance. Jeff serves on the Board of Directors of the Council for Entrepreneurial Development in Durham, and has served on various panels for the North Carolina Biotech Center and SE BIO.


Beth A. Winkelstein, PhD

Professor of Bioengineering and Neurosurgery, and Vice Provost for Education University of Pennsylvania

winkelsteinfinal

BETH WINKELSTEIN, PhD IS A PROFESSOR OF BIOENGINEERING AND NEUROSURGERY at the University of Pennsylvania.  She received her BSE in Bioengineering from Penn and earned a PhD in BME from Duke focused on neck injury biomechanics.  She joined Penn’s faculty in 2002 after completing a post-doctoral fellowship in the neuroimmunology of pain in Anesthesiology & Pharmacology at Dartmouth.  Dr. Winkelstein’s lab studies the biomechanical mechanisms of painful spine and joint injuries, and is defining the pathophysiological cellular mechanisms driving chronic pain, mechanotransduction of pain, and potential diagnostic and therapeutic approaches for these disorders.  Her group has pioneered several preclinical models of painful tissue injuries, which are the first injury models with clinically-relevant symptoms. Her group implements rigorous engineering analyses in these in vivo systems to define biomechanical metrics and relate them to complicated neuronal plasticity responses throughout the nervous system. Her group is developing new imaging approaches to understand subfailure micro- and macro-scale biomechanical tissue responses, and has expanded that work to include functional imaging to identify cellular activation networks in the brain and spinal cord.  She funds her lab through grants from the Whitaker Foundation, NSF, NHTSA, CDC, NIH (NINDS, NIAMS, NIBIB, NCCIH), CSRS, DOD, OMSF, and several industry partners. She has published over 115 peer-reviewed papers, 16 book chapters and the book Orthopaedic Biomechanics, and holds a patent. Dr. Winkelstein is a Fellow of the BMES and ASME, and was elected to AIMBE. She was awarded a Whitaker Young Investigator Award, NIH Career Award, NSF-CAREER Award, the ASME Fung Young Investigator Award for the most promising young Bioengineer, and the ASME Mow Medal for contributions to the field of bioengineering through research, education, professional development, leadership and mentorship. Dr. Winkelstein has served as primary research mentor for 36 graduate students and postdoctoral fellows, and over 60 undergraduates. She serves on the Editorial Board for Spine and serves as the Co-Editor of the Journal of Biomechanical Engineering since 2012. She has served as the Bioengineering Graduate Group Chair and the Associate Dean of Undergraduate Education at Penn, and has been the faculty adviser for Penn’s BMES chapter since 2008. She has also served as the faculty adviser for Penn’s student SWE chapter. She is on the Board of Directors of the BMES is actively involved in the ASME-SBC, the World Congress of Biomechanics, and several clinical meetings.


Christopher Withnall

Senior Engineer, Biokinetics and Associates Ltd.

withnallfinal

CHRIS WITHNALL MANAGES RESEARCH AND DEVELOPMENT in sports impact biomechanics. He has designed helmets for construction safety, firefighting, riot police, bicycle, football, hockey and military applications as well as other human protection systems since joining Biokinetics in 1990. Chris conducted several years of NFL concussion research on concussion tolerance, helmets and mouth guards. Varied research includes airbags, side impact, safety in soccer, riot police injury, ballistic armour degradation, auto racing head protection and head impact research with artificial turf. Chris has authored 18 peer reviewed articles and is a contributing member of the Canadian Standards Association and American Society for Testing and Materials.